Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A-Reference-Cited by-同舟云学术

Individualised prophylaxis based on personalised target trough FVIII level optimised clinical outcomes in paediatric patients with severe haemophilia A

Published:2022-07-18 Issue:6 Volume:28 Page:
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Huang Kun¹^ORCID,Ai Di¹^ORCID,Li Gang²,Zhen Yingzi¹,Wang Yan³,Zhang Ningning⁴,Huo Aihua⁴,Liu Guoqing¹,Chen Zhenping²^ORCID,Wu Runhui¹^ORCID

Affiliation:

1. Hematology Center, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China

2. Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China

3. Rehabilitation Department, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China

4. Radiology Center, Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14635

Reference27 articles.

1. WFH Guidelines for the Management of Hemophilia, 3rd edition

2. Haemophilia;Berntorp E;Nat Rev Dis Prim,2021

3. Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A